2.5 mg of tirzepatide Tirzeparo 2.5mg Tirzepatide (Month 1) 2.5mg |

Strengthening reimbursement pathways, including emerging Medicare coverage initiatives, are easing affordability constraints that previously limited adoption

Semaglutide may be appropriate for adults who: Have type 2 diabetes with inadequate control on lower doses Struggle with obesity or weight-related metabolic issues Require improved insulin sensitivity Are seeking a medically supervised weight loss solution Want to reduce long-term cardiovascular risk This medication is not intended for individuals with type 1 diabetes or those without medical guidance

That said, therapy must be carefully monitored

Diabetes can damage nerves and blood vessels over time, which may lead to sexual problems

Typically, no

An A1C at or above 6.5% meets the diagnostic threshold for type 2 diabetes when confirmed with repeat testing